← Back to patent-cliff list
CAS 32750-26-8
2-(tert-butyl)-6-iodo-4-nitrophenol
Codes: DASA-021
Application context (from source-drug indications)
Chronic hepatitis CDasabuvir Sodium HydrateHepatitis CDasabuvir Sodium HydrateDecompensated cirrhosisDasabuvir Sodium HydrateRenal impairmentDasabuvir Sodium HydrateFibrosisDasabuvir Sodium HydrateEnd-stage renal diseaseDasabuvir Sodium Hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Dasabuvir Sodium Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(tert-butyl)phenol→2-(tert-butyl)-4-nitrophenol→N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-yl)methanesulfonamide→(E)-3-methoxyacryloyl isocyanate→1-(3-(tert-butyl)-5-iodo-4-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione→2-(tert-butyl)-6-iodo-4-nitrophenol→1-(tert-butyl)-3-iodo-2-methoxy-5-nitrobenzene→3-(tert-butyl)-5-iodo-4-methoxyaniline→(E)-N-((3-(tert-butyl)-5-iodo-4-methoxyphenyl)carbamoyl)-3-methoxyacrylamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.